06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

ex porter, dis trib u tor, pro moter, sales/detailer.<br />

Prod uct ranges in clude: phar ma ceu ti cal prod ucts<br />

(branded, pre scrip tion), bio tech nol ogy products.<br />

Established 1997.<br />

Con tacts (Pharm): Chair man: Bill Fullagar;<br />

Com mer cial Op er a tions: Justin Van Gennep;<br />

Man u fac ture: Mike Benzie; Mar ket Re search: Da -<br />

vid Hor ton; Re search & De vel op ment: Lester<br />

Whitbread<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 700-750 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 50-55%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 60-65%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

80-85%<br />

Prin ci pal Prod ucts:<br />

GLIVEC (antineoplastic other)<br />

DIOVAN (an gio ten sin-II an tag o nist plain)<br />

LUCENTIS (oc u lar antineovascularization prod -<br />

uct)<br />

NEORAL (immunosuppressive agent)<br />

FEMARA (cytostatic hor mone an tag o nist)<br />

Ther a peu tic Range:<br />

antineoplastics 17%<br />

renin-an gio ten sin sys tem agents 16%<br />

ophthalmologicals 13%<br />

immunosuppressive agents 8%<br />

cytostatic hor mone ther apy 6%<br />

Lead ing Dose Forms:<br />

coated tab lets 31%<br />

cap sules 24%<br />

tab lets 11%<br />

vi als 10%<br />

in fu sions 7%<br />

SANDOZ<br />

Full Name: Sandoz Ltd<br />

Street Ad dress: Unit 37, Woolmer Way, Bordon,<br />

Hamp shire GU35 9QE<br />

Tel: +44 1420 478301<br />

Fax: +44 1420 474427<br />

Home Page: www.uk.sandoz.com<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 85-90 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 45-50%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 55-60%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

GABAPENTIN SANDOZ (antiepileptic)<br />

CLINDAMYCIN SANDOZ (macrolide/sim i lar type)<br />

BEDRANOL (beta-blocker agent plain)<br />

FENTANYL SANDOZ (an al ge sic nar cotic)<br />

RAMIPRIL SANDOZ (ACE in hib i tor plain)<br />

Ther a peu tic Range:<br />

antibacterials sys temic 15%<br />

an al ge sics 14%<br />

antiepileptics 13%<br />

beta-block ing agents 9%<br />

anti rheu ma tics sys temic 9%<br />

Lead ing Dose Forms:<br />

cap sules 50%<br />

coated tab lets 20%<br />

tab lets 10%<br />

med i cal dress ings 8%<br />

liq uids 6%<br />

TILLOMED<br />

Full Name: Tillomed Lab o ra to ries Lim ited<br />

Street Ad dress: 3 Howard Road, Eaton Socon,<br />

St Neots, Cam bridge shire PE19 3ET<br />

Tel: +44 1480 402400<br />

Fax: +44 1480 402402<br />

Email: en qui ries@tillomed.co.uk<br />

Home Page: www.tillomed.com<br />

De scrip tion: Prod uct ranges in clude: phar ma -<br />

ceu ti cal prod ucts (branded, unbranded). Es tab -<br />

lished 1991.<br />

Con tacts (Pharm): Chair man: Musharraf Ginai;<br />

Gen eral Con tact: Musharraf Ginai<br />

UKRAINE<br />

HEXAL<br />

Full Name: Hexal AG<br />

Street Ad dress: 145 Borschagivska str., 03056<br />

Kiev<br />

Phar ma ceu ti cal Sales: US$ 20-22 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 60-65%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 75-80%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

85-90%<br />

Prin ci pal Prod ucts:<br />

DICLAC (antirheumatic top i cal; antirheumatic<br />

non-steroidal)<br />

ACC (ex pec to rant)<br />

ACC LONG (ex pec to rant)<br />

ACC HOT DRINK (ex pec to rant)<br />

ACIC (vi ral in fec tion prod uct top i cal; an ti vi ral<br />

non-HIV)<br />

Ther a peu tic Range:<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 218

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!